A prospective study of circulating mutant KRAS2 in the serum of patients with colorectal neoplasia: strong prognostic indicator in postoperative follow up
Reprinted with permission from Gut:
Please note that this article was originally printed in Gut and the correct citation for this article is:
A prospective study of circulating mutant KRAS2 in the serum of patients with colorectal neoplasia: strong prognostic indicator
in postoperative
follow up
B M Ryan, F Lefort, R McManus, J Daly, P W N Keeling, D G Weir, and D Kelleher
Gut 2003; 52: 101-108.
The publishers apologise for any confusion that this might cause
About the toc
-
doi: 10.1136/mp.56.3.172 Mol Path 1 June 2003 vol. 56 no. 3 172-179
